Neurocrine Biosciences
NBIX
#1573
Rank
$13.20 B
Marketcap
$131.60
Share price
-0.72%
Change (1 day)
21.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company